Ann Zauber

Last updated

Ann Graham Zauber is an epidemiologist and biostatistician at the Memorial Sloan Kettering Cancer Center, primarily interested in colorectal cancer. [1] Her research has demonstrated the effectiveness of colonoscopy and polyp removal at reducing the incidence of this kind of cancer. [2]

Zauber did her Ph.D. in biostatistics at Johns Hopkins University. [3] She became a Fellow of the American Statistical Association in 2016. [4]

In 2018 the World Endoscopy Organization gave her their Charles G. Moertel Distinguished Scientific Achievement Award. [5]

Related Research Articles

Colonoscopy Endoscopic examination of the bowel

Colonoscopy or coloscopy is the endoscopic examination of the large bowel and the distal part of the small bowel with a CCD camera or a fiber optic camera on a flexible tube passed through the anus. It can provide a visual diagnosis and grants the opportunity for biopsy or removal of suspected colorectal cancer lesions.

Memorial Sloan Kettering Cancer Center Hospital in New York City, US

Memorial Sloan Kettering Cancer Center is a cancer treatment and research institution in the borough of Manhattan in New York City, founded in 1884 as the New York Cancer Hospital. MSKCC is the largest and oldest private cancer center in the world, and is one of 52 National Cancer Institute–designated Comprehensive Cancer Centers. Memorial Sloan Kettering is affiliated with Cornell University's medical school. Its main campus is located at 1275 York Avenue, between 67th and 68th streets, in Manhattan.

José Baselga Spanish oncologist

Josep Baselga i Torres, known in Spanish as José Baselga was a Spanish medical oncologist and researcher focused on the development of novel molecular targeted agents, with a special emphasis in breast cancer. Through his career he was associated with the Memorial Sloan Kettering Cancer Center, Vall d'Hebron Institute of Oncology, and the Massachusetts General Hospital in their hematology and oncology divisions. He led the development of the breast cancer treatment Herceptin, a monoclonal antibody, that targets the HER2 protein which is impacted in aggressive breast cancers.

Joseph F. Fraumeni Jr. American physician

Joseph F. Fraumeni Jr. is an American physician and cancer researcher. Born in Boston, he received an A.B. from Harvard College, an M.D. from Duke University, and an M.Sc. in epidemiology from the Harvard School of Public Health. He completed his medical residency at Johns Hopkins Hospital and Memorial Sloan-Kettering Cancer Center. He then joined the National Cancer Institute at the National Institutes of Health in 1962 as a commissioned officer of the U.S. Public Health Service, becoming the founding Director of the Division of Cancer Epidemiology and Genetics in 1995. He stepped down from this position in 2012 to become a senior investigator and advisor to the National Cancer Institute.

Joan Massagué

Joan Massagué, is a Spanish biologist and the current director of the Sloan Kettering Institute at Memorial Sloan Kettering Cancer Center. He is also an internationally recognized leader in the study of both cancer metastasis and growth factors that regulate cell behavior, as well as a professor at the Weill Cornell Graduate School of Medical Sciences.

Thomas J. Kelly is an American cancer researcher whose work focuses on the molecular mechanisms of DNA replication. Kelly is director of the Sloan-Kettering Institute, the basic research arm of the Memorial Sloan-Kettering Cancer Center. He holds the Center's Benno C. Schmidt Chair of Cancer Research.

Douglas Kevin Rex is an American gastroenterologist who teaches at Indiana University School of Medicine. He is well known for his prolific publishing in the field of gastroenterology particularly in colonoscopy and colorectal cancer screening and is widely regarded as one of the doctors who established colonoscopy as a safe and effective procedure. He played a key role in Medicare reimbursement for colonoscopy resulting in adoption of the procedure as a colorectal cancer screening tool in the US.

Peter Bach Medical researcher

Peter B. Bach is a physician and writer at Memorial Sloan-Kettering Cancer Center where he is Director of the Center for Health Policy and Outcomes. His research focuses on healthcare policy, particularly as it relates to Medicare, racial disparities in cancer care quality, and lung cancer. Along with his scientific writings he is a frequent contributor to The New York Times and other newspapers.

Paul Alan Marks was a medical doctor, researcher and administrator. He was a faculty member and president at Memorial Sloan Kettering Cancer Center.

Ralph H. Hruban is professor of pathology and oncology at the Johns Hopkins School of Medicine. He is currently Director of the Sol Goldman Pancreatic Cancer Research Center at Johns Hopkins, and Baxley Professor and Director of the Department of Pathology. He is a world expert on pancreatic cancer.

The Paul Marks Prize for Cancer Research is awarded by the Memorial Sloan Kettering Cancer Center to recognize cancer researchers who are making significant contributions to the understanding of cancer or are improving the treatment of the disease through basic or clinical research.

Nikola Panayot Pavletich is the chair of structural biology at Memorial Sloan Kettering Cancer Center.

Marilyn Nancy Lorch Geller is an American biostatistician, the director of biostatistics research at the National Heart, Lung, and Blood Institute and a former president of the American Statistical Association.

David A. Scheinberg, M.D., Ph.D. is a physician, scientist, drug developer, and entrepreneur, who is currently Vincent Astor Chair, and Chairman of the Molecular Pharmacology Program at Memorial Sloan Kettering Cancer Center (MSK). He is a pioneer and inventor of targeted alpha particle therapies and alpha particle generators for use in patients with cancer.

Luis Alberto Diaz, Jr. is the Head of the Division of Solid Tumor Oncology in Memorial Sloan Kettering’s Department of Medicine.

Colin B. Begg is a Scottish biostatistician and epidemiologist. He is an attending biostatistician at the Memorial Sloan-Kettering Cancer Center in New York City. He serves as editor-in-chief of the journal Clinical Trials. He has conducted research on the role of BRCA genetic variants in the development of breast cancer, as well as racial disparities in cancer survival rates in the United States.

Helen Abbey was an American biostatistician known for her research on the health effects of radiation and on infections among Native Americans, and for her prolific mentoring of students in statistics. She was affiliated with Johns Hopkins University for over 50 years.

Dr. Kathleen M. Foley is an American physician. She was an Attending Neurologist at Memorial Sloan-Kettering Cancer Center in New York City. She worked as a professor of Neurology, Neuroscience, and Clinical Pharmacology at Cornell University Weill Medical College. Foley made contributions toward making palliative care for cancer patients accessible. She headed the country's first pain service in a cancer center at Memorial Sloan-Kettering and was the medical director of the Supportive Care Program. In 1999, she became the director of the Open Society Institute’s Project on Death in America. Additionally, Foley was the Director of the WHO Collaborating Center for Cancer Pain Research and Education at Memorial Sloan-Kettering Cancer Center. She holds the Chair of the Society of Memorial Sloan-Kettering Cancer Center in Pain Research and continues to work with the Open Society Institute as the Medical Director of the International Palliative Care Initiative of the Network Public Health Program of the Research.

Lisa DeAngelis

Lisa Marie DeAngelis is an American neuro-oncologist and Physician-in-Chief and Chief Medical Officer at Memorial Sloan Kettering Cancer Center.

Valerie W Rusch, MD, FACS, is an American thoracic surgeon who is currently the Miner Family Chair for Intrathoracic Cancers and Vice Chair for Clinical Research, Department of Surgery, at Memorial Sloan Kettering Cancer Center.

References

  1. "Profile: Ann Zauber". Memorial Sloan Kettering Cancer Center. Archived from the original on 2018-08-07. Retrieved 2018-08-07.
  2. Grady, Denise (February 22, 2012). "Report Affirms Lifesaving Role of Colonoscopy". Health. The New York Times . Archived from the original on August 7, 2018. Retrieved August 7, 2018.
  3. Rohde, Charles; Zeger, Scott L.; Thomas, Karen Kruse; Bandeen-Roche, Karen (2012). "Johns Hopkins University Department of Biostatistics". In Agresti, Alan; Meng, Xiao-Li (eds.). Strength in Numbers: The Rising of Academic Statistics Departments in the U. S. New York: Springer. pp. 129–141. doi:10.1007/978-1-4614-3649-2_10. (See in particular p. 134 Archived 2022-08-04 at the Wayback Machine .)
  4. "ASA Bestows Fellows Designation on 65 Members" (PDF). American Statistical Association. June 20, 2016. Archived (PDF) from the original on 2018-08-20. Retrieved 2018-08-07.
  5. "Ann Graham Zauber presented with the Charles G. Moertel Distinguished Scientific Achievement Award for her dedication to Colorectal Cancer Prevention". World Endoscopy Organization. Archived from the original on 2022-08-04. Retrieved 2018-08-07.(need better cit)